Clinical trials
Phase 3 Gastroesophageal Reflux trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 2 |
| 2018 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| Eisai Inc. | 2 |
| Ironwood Pharmaceuticals, Inc. | 2 |
| Cogentus Pharmaceuticals | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastroesophageal Reflux | 13 |
| Dyspepsia | 2 |
| Acute Coronary Syndrome | 1 |
| Cerebrovascular Disorders | 1 |
| Chest Pain | 1 |
| Coronary Artery Disease | 1 |
| Coronary Thrombosis | 1 |
| Duodenal Obstruction | 1 |
| Duodenal Ulcer | 1 |
| Esophagitis, Peptic | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.